Matthew Strobeck
Director at QuidelOrtho Corp (QDEL)
Matthew Strobeck has filed 37 insider reports with the SEC since February 2021, as director at QuidelOrtho Corp (QDEL), director at Biodesix Inc (BDSX) and director at Accelerate Diagnostics, Inc (AXDX). In the last 12 months Matthew Strobeck bought $240K of stock on the open market. The latest filing, on June 2, 2026, reports grant or award and exercise or conversion of a derivative at QuidelOrtho Corp (QDEL).
- Filings
- 37
- Companies
- 3
- Bought on market
- $6.01M
- Sold on market
- None
Companies where Matthew Strobeck is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 34,604 | $240K | $23.96 | $8.32-65% | Jun 2, 2026 | ||
| Director | 2,542,928 | $5.77M | $1.45 | $7.56+421% | Jan 6, 2026 | ||
| Director | 202,556 | Jan 25, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- May 29, 2026QDELDirector Strobeck Matthew was granted 6,829 shares, increasing direct ownership by 25% to 34,604 unitsForm 4Grant or awardExercise or conversion of a derivative
- Feb 13, 2026+$240KQDELDirector Strobeck Matthew bought $239,586 worth of shares (10,000 units at $23.96), increasing direct ownership by 56% to 27,775 unitsForm 4Open-market purchase
- Jan 2, 2026BDSXSEC Form 4 filed by Director Strobeck MatthewForm 4Grant or award
- May 29, 2025QDELSEC Form 4 filed by Director Strobeck MatthewForm 4Grant or award
- May 22, 2025QDELDirector Strobeck Matthew was granted 4,929 shares, increasing direct ownership by 38% to 17,775 unitsForm 4Grant or awardExercise or conversion of a derivative
- May 20, 2025BDSXSEC Form 4 filed by Director Strobeck MatthewForm 4Grant or award
- Nov 5, 2024+$55.9KBDSXDirector Strobeck Matthew bought $55,916 worth of shares (40,000 units at $1.40)Form 4Open-market purchase
- May 24, 2024QDELStrobeck Matthew was granted 2,416 shares, increasing direct ownership by 23% to 12,846 unitsForm 4Grant or awardExercise or conversion of a derivative
- May 23, 2024BDSXStrobeck Matthew converted options into 347,840 sharesForm 4Grant or awardExercise or conversion of a derivative
- May 22, 2024QDELSEC Form 4 filed by Strobeck MatthewForm 4Grant or award
- Apr 5, 2024BDSXSEC Form 4 filed by Strobeck MatthewForm 4Grant or award
- Jan 23, 2024AXDXStrobeck Matthew bought 100,000 sharesForm 4Open-market purchase
- Jan 1, 2024BDSXSEC Form 4 filed by Strobeck MatthewForm 4Grant or award
- Aug 3, 2023BDSXSEC Form 4: Strobeck Matthew was granted 308,640 shares, increasing direct ownership by 5% to 2,542,928 unitsForm 4Grant or award
- Jun 28, 2023AXDXSEC Form 4 filed by Strobeck MatthewForm 4Grant or award
- Jun 6, 2023QDELSEC Form 4 filed by Strobeck MatthewForm 4Grant or awardExercise or conversion of a derivative
- May 29, 2023AXDXSEC Form 4 filed by Strobeck MatthewForm 4Grant or award
- May 24, 2023QDELSEC Form 4 filed by Strobeck MatthewForm 4Grant or award
- May 23, 2023BDSXSEC Form 4 filed by Strobeck MatthewForm 4Grant or award
- May 18, 2023QDELSEC Form 4 filed by Strobeck MatthewForm 4Grant or awardExercise or conversion of a derivative
- May 14, 2023QDELSEC Form 4 filed by Strobeck MatthewForm 4Grant or awardExercise or conversion of a derivative
- Jan 3, 2023BDSXSEC Form 4 filed by Strobeck MatthewForm 4Grant or award
- Jan 1, 2023BDSXSEC Form 4 filed by Strobeck MatthewForm 4Grant or award
- Nov 21, 2022+$3.07MBDSXSEC Form 4: Strobeck Matthew bought $3,069,996 worth of shares (2,669,562 units at $1.15), increasing direct ownership by 56% to 2,415,151 unitsForm 4Open-market purchase
- May 31, 2022AXDXSEC Form 4 filed by Strobeck MatthewForm 4Grant or award
- May 27, 2022QDELSEC Form 4: Strobeck Matthew returned 61,308 shares to the company, closing all direct ownership in the companyForm 4Sale back to the company
- May 24, 2022BDSXSEC Form 4 filed by Strobeck MatthewForm 4Grant or award
- May 18, 2022QDELSEC Form 4: Strobeck Matthew converted options into 1,624 shares, increasing direct ownership by 33% to 6,533 unitsForm 4Exercise or conversion of a derivative
- Apr 7, 2022+$2MBDSXSEC Form 4: Strobeck Matthew bought $1,999,999 worth of shares (1,117,318 units at $1.79), increasing direct ownership by 57% to 1,545,586 unitsForm 4Open-market purchase
- Mar 31, 2022BDSXSEC Form 4: Strobeck Matthew converted options into 20,044 shares, increasing direct ownership by 2% to 986,927 unitsForm 4Exercise or conversion of a derivative
- Dec 30, 2021+$643KBDSXSEC Form 4: Strobeck Matthew bought $642,930 worth of shares (147,800 units at $4.35)Form 4Open-market purchase
- Sep 30, 2021AXDXSEC Form 4: Strobeck Matthew was granted 19,531 sharesForm 4Grant or award
- May 20, 2021AXDXSEC Form 4 filed by Strobeck MatthewForm 4Grant or award
- May 18, 2021QDELSEC Form 4 filed by Strobeck MatthewForm 4Grant or award
- May 12, 2021QDELSEC Form 4: Strobeck Matthew exercised 1,040 units of Common Stock at a strike of $0.00, increasing direct ownership by 27% to 4,909 unitsForm 4Exercise or conversion of a derivative
- Apr 9, 2021AXDXSEC Form 4: Strobeck Matthew was granted 19,531 units of Common StockForm 4Grant or award
- Feb 19, 2021AXDXSEC Form 4: Matthew Strobeck was granted 19,531 units of Common StockForm 4Grant or award
Also sits on boards with
Officers and directors who share two or more companies with Matthew Strobeck.
- John Patience2 shared: BDSX, AXDX
- Hany Massarany2 shared: BDSX, AXDX
- Charles M Watts2 shared: BDSX, AXDX
Compare Matthew Strobeck with
- Matthew Strobeck vs Jack W Schuler2 shared
- Matthew Strobeck vs John Patience2 shared
- Matthew Strobeck vs Hany Massarany2 shared
- Matthew Strobeck vs Charles M Watts2 shared
- Matthew Strobeck vs Ronald Lee Bowman1 shared
- Matthew Strobeck vs Bryan Michael Hanson1 shared
Other insiders at the same companies
- Jack W SchulerBDSX
- Ronald Lee BowmanQDEL
- Bryan Michael HansonQDEL
- Micah W YoungQDEL
- Kenneth J WidderQDEL
- R Scott HuennekensQDEL
- John R ChiminskiQDEL
- Joseph D Wilkins Jr.QDEL
- Ann D RhoadsQDEL
- Polan Mary Lake Ph DQDEL
- Edward L. MichaelQDEL
- Evelyn S DilsaverQDEL
- Kenneth F BuechlerQDEL
- Brian J. BlaserQDEL
- Philip D. McLellanQDEL
Questions about Matthew Strobeck
- What is Matthew Strobeck's role at QuidelOrtho Corp?
- Matthew Strobeck reports to the SEC as director at QuidelOrtho Corp (QDEL), according to the latest filing on June 2, 2026. Matthew Strobeck has also filed as director at Biodesix Inc (BDSX) and director at Accelerate Diagnostics, Inc (AXDX).
- How many shares does Matthew Strobeck own?
- After the latest filing that states it, Matthew Strobeck directly owned 34,604 shares of QuidelOrtho Corp (QDEL), 2,542,928 shares of Biodesix Inc (BDSX) and 202,556 shares of Accelerate Diagnostics, Inc (AXDX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Matthew Strobeck bought or sold stock recently?
- The most recent open-market purchase was on February 13, 2026: bought 10,000 shares of QuidelOrtho Corp (QDEL) for $240K at an average of $23.96.
- How do I get alerts when Matthew Strobeck files?
- Follow Matthew Strobeck on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Matthew Strobeck (SEC CIK 0001377832). Totals count each trade once, skipping amendments whose original is on file, from Feb 24, 2021 on. View on SEC EDGAR · Get this as JSON